Autologous Hematopoietic Stem Cell Transplantation for High-risk Acute Lymphoblastic Leukemia: non-Randomized Study with a maximum Follow-up of more than 22 Years.

Mediterr J Hematol Infect Dis · 2014 · PMC4103509 · PMID 25045455

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a strong trendp=0.06so close (0.05 < p ≤ 0.1)

There was a strong trend towards better LFS at 10 years for patients with negative MRD at transplant when compared with subjects who had positive or unknown MRD (32% vs 23% vs 25%; p=0.06).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.